Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT01009580

Femme et Homme

Extrait

This trial is conducted in Asia, Europe and Oceania. The aim of this clinical trial is to compare NN5401 (insulin degludec/insulin aspart) with biphasic insulin aspart 30 in subjects with type 2 diabetes.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 2


Liens